Last reviewed · How we verify
NCT05692258: ZCFZZLXGBDFYHZ
Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia
NA trial testing Acupuncture in Acupuncture in 146 participants. Status unknown.
6 April 2023
Quick facts
| Lead sponsor | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 146 |
| Start date | 6 January 2023 |
| Primary completion | 6 April 2023 |
| Estimated completion | 6 April 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Acupuncture — full drug profile →
Conditions studied
- Acupuncture — all drugs for Acupuncture →
- Covid-19 Omicron — all drugs for Covid-19 Omicron →
- Pulmonary Function — all drugs for Pulmonary Function →
Sponsor
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Who can join
30 and older, any sex, with Acupuncture or Covid-19 Omicron. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
At present, China is facing the first wave of COVID-19 epidemic after the liberalization. The infection rate has exceeded 50% in most areas, and even exceeded 80% in some cities. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the beta genus of coronavirus and enters cells mainly by binding angiotensin converting enzyme 2 (ACE-2) to the spike protein on the envelope. The Omicron strain is the main epidemic strain at present. The transmission ability of Omicron strain is stronger than Delta strain, but the pathogenicity is weakened. At present, the published articles on the adjuvant treatment of COVID-19 with acupuncture are mostly theoretical discussions or case reports, and randomized controlled trials on the observation of curative effect are rare. The purpose of this study is to clarify the effectiveness of the adjuvant treatment of COVID-19 with acupuncture. Providing high-level research evidence for them.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05692258
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Acupuncture
Trials testing the same drug.
- NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures · NA · not yet recruiting
- NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
- NCT07522710 — Clinical Study on Intensive Multi-acupuncture in the Treatment of Neck and Shoulder Myofascial Pain Syndrome · NA · not yet recruiting
- NCT07505927 — Acupuncture for Postoperative Gastric Emptying Delay · NA · not yet recruiting
- NCT07410793 — Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. · Phase 2 · recruiting
Other recruiting trials for Acupuncture
Currently open trials in the same condition.
- NCT06910540 — ACU-TENS on Pain and Stress Reduction Before and During TUGOR · NA · recruiting
- NCT06725550 — Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 · NA · recruiting
- NCT07036393 — Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries · NA · recruiting
- NCT07058259 — Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD · NA · active not recruiting
- NCT06757023 — A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment · recruiting
Other The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT06982755 — Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal · Phase 1, PHASE2 · not yet recruiting
- NCT05924854 — The Influence of Electroacupuncture on Postoperative Agitation of Pediatrics Undergoing Sevoflurane General Anesthesia · NA · unknown
- NCT05743218 — Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve · NA · unknown
- NCT05749354 — Clinical Efficacy of Acupuncture on the Liver Meridian in Men With Erectile Dysfunction Reserve · NA · unknown
- NCT06833541 — Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05692258 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- Last refreshed: 20 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05692258.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing